P20827 (EFNA1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 130.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Ephrin-A1 Alternative name(s): EPH-related receptor tyrosine kinase ligand 1 Short name=LERK-1 Immediate early response protein B61 Tumor necrosis factor alpha-induced protein 4 Short name=TNF alpha-induced protein 4 Cleaved into the following chain: | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 205 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Cell surface GPI-bound ligand for Eph receptors, a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development. Binds promiscuously Eph receptors residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. Plays an important role in angiogenesis and tumor neovascularization. The recruitment of VAV2, VAV3 and PI3-kinase p85 subunit by phosphorylated EPHA2 is critical for EFNA1-induced RAC1 GTPase activation and vascular endothelial cell migration and assembly. Exerts anti-oncogenic effects in tumor cells through activation and down-regulation of EPHA2. Activates EPHA2 by inducing tyrosine phosphorylation which leads to its internalization and degradation. Acts as a negative regulator in the tumorigenesis of gliomas by down-regulating EPHA2 and FAK. Can evoke collapse of embryonic neuronal growth cone and regulates dendritic spine morphogenesis. Ref.8 Ref.9 |
| Subunit structure | Monomer. Homodimer. Forms heterodimers with EPHA2. Binds to the receptor tyrosine kinases EPHA2, EPHA3, EPHA4, EPHA5, EPHA6 and EPHA7. Also binds with low affinity to EPHA1. Ref.9 Ref.10 |
| Subcellular location | |
| Tissue specificity | Brain. Down-regulated in primary glioma tissues compared to the normal tissues. The soluble monomeric form is expressed in the glioblastoma multiforme (GBM) and breast cancer cells (at protein level). Ref.8 |
| Induction | By TNF and IL1B/interleukin-1 beta. |
| Post-translational modification | Undergoes proteolysis by a metalloprotease to give rise to a soluble monomeric form. |
| Sequence similarities | Belongs to the ephrin family. Contains 1 ephrin RBD (ephrin receptor-binding) domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| EPHA2 | P29317 | 5 | EBI-715194,EBI-702104 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P20827-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P20827-2) The sequence of this isoform differs from the canonical sequence as follows: 131-152: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 18 | 18 | Ref.6 | |||||||||||||||||||||||||||||||
| Chain | 19 – 182 | 164 | Ephrin-A1 | PRO_0000008353 | ||||||||||||||||||||||||||||||
| Chain | 19 – ? | Ephrin-A1, secreted form | PRO_0000389630 | |||||||||||||||||||||||||||||||
| Propeptide | 183 – 205 | 23 | Removed in mature form Potential | PRO_0000008354 | ||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||
| Domain | 19 – 151 | 133 | Ephrin RBD | |||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||
| Lipidation | 182 | 1 | GPI-anchor amidated serine Potential | |||||||||||||||||||||||||||||||
| Glycosylation | 26 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||
| Disulfide bond | 51 ↔ 92 | Ref.10 Ref.11 | ||||||||||||||||||||||||||||||||
| Disulfide bond | 80 ↔ 140 | Ref.10 Ref.11 | ||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||
| Alternative sequence | 131 – 152 | 22 | Missing in isoform 2. | VSP_017543 | ||||||||||||||||||||||||||||||
| Natural variant | 159 | 1 | D → V. Ref.1 Ref.2 Ref.4 Ref.5 Corresponds to variant rs4745 [ dbSNP | Ensembl ]. | VAR_014791 | ||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 180 | 1 | G → A in AAH32698. Ref.5 | |||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||
| Beta strand | 20 – 24 | 5 | ||||||||||||||||||||||||||||||||
| Helix | 30 – 32 | 3 | ||||||||||||||||||||||||||||||||
| Beta strand | 38 – 41 | 4 | ||||||||||||||||||||||||||||||||
| Beta strand | 46 – 50 | 5 | ||||||||||||||||||||||||||||||||
| Helix | 61 – 63 | 3 | ||||||||||||||||||||||||||||||||
| Beta strand | 67 – 72 | 6 | ||||||||||||||||||||||||||||||||
| Helix | 74 – 79 | 6 | ||||||||||||||||||||||||||||||||
| Helix | 85 – 87 | 3 | ||||||||||||||||||||||||||||||||
| Beta strand | 88 – 92 | 5 | ||||||||||||||||||||||||||||||||
| Beta strand | 98 – 100 | 3 | ||||||||||||||||||||||||||||||||
| Beta strand | 103 – 107 | 5 | ||||||||||||||||||||||||||||||||
| Beta strand | 125 – 134 | 10 | ||||||||||||||||||||||||||||||||
| Beta strand | 142 – 147 | 6 | ||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein." Holzman L.B., Marks R.M., Dixit V.M. Mol. Cell. Biol. 10:5830-5838(1990) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT VAL-159. |
| [2] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B. Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT VAL-159. |
| [3] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANT VAL-159. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT VAL-159. Tissue: Liver. |
| [6] | "Signal peptide prediction based on analysis of experimentally verified cleavage sites." Zhang Z., Henzel W.J. Protein Sci. 13:2819-2824(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 19-33. |
| [7] | "Ligands for the receptor tyrosine kinases hek and elk: isolation of cDNAs encoding a family of proteins." Kozlosky C.J., Maraskovsky E., McGrew J.T., Vanden Bos T., Teepe M., Lyman S.D., Srinivasan S., Fletcher F.A., Gayle R.B. III, Cerretti D.P., Beckmann M.P. Oncogene 10:299-306(1995) [PubMed] [Europe PMC] [Abstract] Cited for: GPI-ANCHOR. |
| [8] | "Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK." Liu D.-P., Wang Y., Koeffler H.P., Xie D. Int. J. Oncol. 30:865-871(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY. |
| [9] | "Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor." Wykosky J., Palma E., Gibo D.M., Ringler S., Turner C.P., Debinski W. Oncogene 27:7260-7273(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, PROTEOLYTIC CLEAVAGE. |
| [10] | "Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex." Himanen J.P., Goldgur Y., Miao H., Myshkin E., Guo H., Buck M., Nguyen M., Rajashankar K.R., Wang B., Nikolov D.B. EMBO Rep. 10:722-728(2009) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 19-147 IN COMPLEX WITH EPHA2, SUBUNIT, DISULFIDE BOND, GLYCOSYLATION AT ASN-26. |
| [11] | "Ephrin A1 bound to the ligand binding domain of the human ephrin A2 (EPHA2) receptor protein kinase." Structural genomics consortium (SGC) Submitted (FEB-2009) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 19-171 IN COMPLEX WITH EPHA2, DISULFIDE BONDS. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M57730 mRNA. Translation: AAA58388.1. CR457416 mRNA. Translation: CAG33697.1. AL691442 Genomic DNA. Translation: CAI15319.1. AL691442 Genomic DNA. Translation: CAI15320.1. CH471121 Genomic DNA. Translation: EAW53131.1. CH471121 Genomic DNA. Translation: EAW53132.1. BC032698 mRNA. Translation: AAH32698.1. BC095432 mRNA. Translation: AAH95432.1. | ||||||||||||||||||||||||
| IPI | IPI00025840. IPI00377015. | ||||||||||||||||||||||||
| PIR | A36377. | ||||||||||||||||||||||||
| RefSeq | NP_004419.2. NM_004428.2. NP_872626.1. NM_182685.1. | ||||||||||||||||||||||||
| UniGene | Hs.516664. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | P20827. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| DIP | DIP-98N. | ||||||||||||||||||||||||
| IntAct | P20827. 5 interactions. | ||||||||||||||||||||||||
| MINT | MINT-1393983. | ||||||||||||||||||||||||
| STRING | 9606.ENSP00000357392. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | P20827. | ||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||
| DMDM | 73920206. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PaxDb | P20827. | ||||||||||||||||||||||||
| PRIDE | P20827. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| DNASU | 1942. | ||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000368406; ENSP00000357391; ENSG00000169242. ENST00000368407; ENSP00000357392; ENSG00000169242. | ||||||||||||||||||||||||
| GeneID | 1942. | ||||||||||||||||||||||||
| KEGG | hsa:1942. | ||||||||||||||||||||||||
| UCSC | uc001fhh.3. human. uc001fhi.3. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 1942. | ||||||||||||||||||||||||
| GeneCards | GC01P155099. | ||||||||||||||||||||||||
| H-InvDB | HIX0116282. HIX0116386. | ||||||||||||||||||||||||
| HGNC | HGNC:3221. EFNA1. | ||||||||||||||||||||||||
| HPA | CAB032498. | ||||||||||||||||||||||||
| MIM | 191164. gene. | ||||||||||||||||||||||||
| neXtProt | NX_P20827. | ||||||||||||||||||||||||
| PharmGKB | PA27656. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | NOG296825. | ||||||||||||||||||||||||
| HOGENOM | HOG000234373. | ||||||||||||||||||||||||
| HOVERGEN | HBG051447. | ||||||||||||||||||||||||
| InParanoid | P20827. | ||||||||||||||||||||||||
| KO | K05462. | ||||||||||||||||||||||||
| OMA | PIHHQED. | ||||||||||||||||||||||||
| OrthoDB | EOG4D52ZP. | ||||||||||||||||||||||||
| PhylomeDB | P20827. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Pathway_Interaction_DB | epha_fwdpathway. EPHA forward signaling. epha2_fwdpathway. EPHA2 forward signaling. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| Bgee | P20827. | ||||||||||||||||||||||||
| CleanEx | HS_EFNA1. | ||||||||||||||||||||||||
| Genevestigator | P20827. | ||||||||||||||||||||||||
| GermOnline | ENSG00000169242. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| Gene3D | 2.60.40.420. 1 hit. | ||||||||||||||||||||||||
| InterPro | IPR008972. Cupredoxin. IPR001799. Ephrin. IPR019765. Ephrin_CS. [Graphical view] | ||||||||||||||||||||||||
| PANTHER | PTHR11304. PTHR11304. 1 hit. | ||||||||||||||||||||||||
| Pfam | PF00812. Ephrin. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PRINTS | PR01347. EPHRIN. | ||||||||||||||||||||||||
| ProDom | PD002533. Ephrin. 1 hit. [Graphical view] [Entries sharing at least one domain] | ||||||||||||||||||||||||
| SUPFAM | SSF49503. Cupredoxin. 1 hit. | ||||||||||||||||||||||||
| PROSITE | PS01299. EPHRIN_RBD_1. 1 hit. PS51551. EPHRIN_RBD_2. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| EvolutionaryTrace | P20827. | ||||||||||||||||||||||||
| GenomeRNAi | 1942. | ||||||||||||||||||||||||
| NextBio | 7865. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | EFNA1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P20827 Secondary accession number(s): D3DV86 Q8N578 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
